Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome
-
Published:2018-05-30
Issue:18
Volume:24
Page:4416-4428
-
ISSN:1078-0432
-
Container-title:Clinical Cancer Research
-
language:en
-
Short-container-title:Clin Cancer Res
Author:
Forget Marie-Andrée, Haymaker Cara, Hess Kenneth R., Meng Yuzhong Jeff, Creasy CaitlinORCID, Karpinets Tatiana, Fulbright Orenthial J., Roszik Jason, Woodman Scott E., Kim Young Uk, Sakellariou-Thompson Donastas, Bhatta Ankit, Wahl Arely, Flores Esteban, Thorsen Shawne T., Tavera René J., Ramachandran Renjith, Gonzalez Audrey M., Toth Christopher L., Wardell Seth, Mansaray Rahmatu, Patel Vruti, Carpio Destiny Joy, Vaughn Carol, Farinas Chantell M., Velasquez Portia G., Hwu Wen-Jen, Patel Sapna P., Davies Michael A., Diab Adi, Glitza Isabella C., Tawbi Hussein, Wong Michael K., Cain Suzanne, Ross Merrick I., Lee Jeffrey E., Gershenwald Jeffrey E., Lucci Anthony, Royal Richard, Cormier Janice N., Wargo Jennifer A., Radvanyi Laszlo G., Torres-Cabala Carlos A., Beroukhim Rameen, Hwu Patrick, Amaria Rodabe N., Bernatchez Chantale
Funder
HHS | NIH | National Cancer Institute (NCI) Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) Miriam and Jim Mulva Melanoma Research Foundation
Publisher
American Association for Cancer Research (AACR)
Subject
Cancer Research,Oncology
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|